Skip to content

IMMOXINA

Active Private limited companyfounded 2011active for 15 yearsTarwestraat 21, 1070 AnderlechtKBO/BCE: BE 0838.723.564

Lifetime

14 annual accounts with figures on one time axis
peak of €160,628 in 2025
€160,628▲ 3.0%
lowest -€134,867 in 2015
€69,794▲ 18.1%
peak of €896,103 in 2025
€896,103▲ 8.4%
€1.0m▼ 13.1%
Board1 name since 2011
1 director
Documentsfilings and deeds
28-04-202694 days before the deadline
2025micro format
The year was quiet, with no large shift from the year before.

Key points

from the 2025 annual accounts

Equity

€896,103 ▲ 8.4%

IMMOXINA has made a profit without a break since 2017.

Turnover

≈ €400,000 estimated

The micro format states no turnover.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

Four of the last ten came late. The 2019 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 6,059 companies had the same profile as IMMOXINA has now. Each dot stands for 16 companies, two years later.

95.8%
were still trading
3.7%
stopped another way
0.4%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 6,059 companies, not a prediction for IMMOXINA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • 565 sharesdeed of 05-09-2011
  • 435 sharesdeed of 05-09-2011
Board & ownership

Recent changes

Share issue · Amendment of the articles 3,000 shares · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0838723564
Amendment of the articles · Legal-form change General meeting of 09-12-2022 · Gazette deed
Incorporation Founding capital of €1,000,000, 1,000 shares · Founded by and · appointed as manager · published on 05-09-2011 · Gazette deed
All 22 events

Official details

Source: KBO
Status
Active since 24-08-2011Normal situation
Activity
“Toutes opérations généralement quelconques se rattachant à l’achat, la vente, l’échange, la gestion, la…” (deed in French)From the articles, 3 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Reachable since 08-01-2026
Company details

Annual accounts 2025

€1.9m▼ 4.2%
Filing
Filed on 28-04-2026, 94 days before the end of the filing period
Financials

Insights on IMMOXINA

IMMOXINA files the micro format. That format states no turnover. The gross margin rose from -€85,131 in 2012 to €160,628 in 2025.

The balance sheet grew most from 2014 to 2016 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about IMMOXINA

What is the company number of IMMOXINA?
The company number of IMMOXINA is 0838.723.564. The VAT number is the same number with BE in front: BE 0838.723.564.
Where is IMMOXINA based?
The registered office is at Tarwestraat 21, 1070 Anderlecht.Company details
What is the legal form of IMMOXINA?
IMMOXINA is a private limited company (BV).
When was IMMOXINA founded?
IMMOXINA was founded on 24-08-2011.
Is IMMOXINA still active?
Yes, IMMOXINA is an active enterprise in the KBO register.
What is the turnover of IMMOXINA?
The turnover in financial year 2025 is about €400,000. This figure is estimated from the gross margin of €160,628 and 2,451 comparable companies of the same size. It probably lies between €260,000 and €620,000. It is a rough estimate.Financials
Is IMMOXINA profitable?
In financial year 2025, IMMOXINA made a profit of €69,794.
Where can I find the annual accounts of IMMOXINA?
IMMOXINA filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of IMMOXINA due?
IMMOXINA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.